Pharmaceutical Preparation Manufacturing federal obligations in FY2025

NAICS 325412 × FY2025 is a yearlyTrend join

Code 325412 and fiscal year 2025 share one cell. $23,869,639,674.33 is the USAspending.gov obligation amount on that cell. It is not Pharmaceutical Preparation Manufacturing's $59,825,795,303.53 all-year total, not every federal drug dollar in FY2025, and not an outlay. Product names, NDC lists, and maker names are unpublished. This packet does not name contractors. Biological product manufacturing (325414) and medicinal and botanical manufacturing (325411) are other codes on this slice.

A large FY2025 pharma cell can look like a single-program medical budget. The facts do not split vaccines from small-molecule products or brand from generic. Ranking makers from this total would invent a table. Correlation with shortage headlines is not causation.

FY2025 against 325412's longer obligation book

39.9% of $59,825,795,303.53 is tagged to FY2025. Other years for NAICS 325412 remain other rows. The Pharmaceutical Preparation Manufacturing hub (/industries/325412/) is the parent without a year filter. FY2025 federal spending (/fiscal-years/2025/) is the parent without a 325412 filter.

Do not add those parents into $23,869,639,674.33. The source note says FY figures can be incomplete. Cite the figure as obligations for NAICS 325412 in FY2025, not as invoices already settled at a named plant.

51,311 pharma award records are extract-wide

51,311 is the Pharmaceutical Preparation Manufacturing award-record count in this extract. It is not FY2025 awards, not unique vendors, and not a count of lots. This page does not divide $23,869,639,674.33 by 51,311 to invent a typical FY2025 pharma contract.

What the 325412 FY2025 cell does not show

No outlays, no product split, no named primes, no state table. FEC filings do not fund these USAspending obligations. All industries (/industries/) and All spending ties (/ties/) hold other keys. Keep Pharmaceutical Preparation Manufacturing and FY2025 on the citation.

Reading 325412's FY2025 overlay neighbors

Follow /industries/325412/ for NAICS 325412, /fiscal-years/2025/ for FY2025 across industries, /industries/ for the industry index, and /ties/ for other joins. Those URLs are larger than this yearlyTrend pair.

Reuse $23,869,639,674.33 only as Pharmaceutical Preparation Manufacturing obligations in FY2025. The 51,311 award-record count stays on the industry extract. Filings remain on USAspending.gov. Keep Pharmaceutical Preparation Manufacturing and FY2025 together when citing $23,869,639,674.33. NAICS 325412's extract-wide award-record count is 51,311, not a FY2025 census. Obligations of $23,869,639,674.33 are not outlays. Original filings remain on USAspending.gov for this 325412 × FY2025 pair. Do not add parent hubs into this yearlyTrend cell. Campaign-finance tables do not fund these USAspending obligations. The 39.9% share is $23,869,639,674.33 divided by the extract-wide $59,825,795,303.53, not a budget score. Unique recipients remain unpublished on this Pharmaceutical Preparation Manufacturing FY2025 join. Agency and place-of-performance splits are omitted from this packet. Quote NAICS 325412, fiscal year 2025, and $23,869,639,674.33 in one sentence. The All industries index and All spending ties index are larger than this cell. A later USAspending ingest can restate $23,869,639,674.33 without changing the join keys. Keep Pharmaceutical Preparation Manufacturing and FY2025 together when citing $23,869,639,674.33. NAICS 325412's extract-wide award-record count is 51,311, not a FY2025 census. Obligations of $23,869,639,674.33 are not outlays. Original filings remain on USAspending.gov for this 325412 × FY2025 pair. Do not add parent hubs into this yearlyTrend cell. Campaign-finance tables do not fund these USAspending obligations. The 39.9% share is $23,869,639,674.33 divided by the extract-wide $59,825,795,303.53, not a budget score. Unique recipients remain unpublished on this Pharmaceutical Preparation Manufacturing FY2025 join. Agency and place-of-performance splits are omitted from this packet. Quote NAICS 325412, fiscal year 2025, and $23,869,639,674.33 in one sentence.

Questions

How much did Pharmaceutical Preparation Manufacturing obligate in FY2025?

USAspending.gov records $23,869,639,674.33 in Pharmaceutical Preparation Manufacturing obligations for FY2025 under NAICS 325412. That yearlyTrend amount is not an outlay and not the $59,825,795,303.53 extract-wide total. Keep Pharmaceutical Preparation Manufacturing and FY2025 on the same citation as $23,869,639,674.33.

Is FY2025 most of 325412's published book?

FY2025 is 39.9% of NAICS 325412's $59,825,795,303.53 extract-wide total. Other fiscal-year rows are separate cells. Do not merge the industry hub into this join. 51,311 is the industry extract award-record count, not a FY2025 headcount.

Do 51,311 awards mean 51,311 FY2025 drug contracts?

No. 51,311 is 325412's extract-wide award-record count, not a FY2025 instrument list. Unique recipients and product splits are unpublished. Obligations of $23,869,639,674.33 are not outlays. The pair is NAICS 325412 plus FY2025. The pair is NAICS 325412 plus FY2025.

Are these outlays to named drug makers?

No. $23,869,639,674.33 is an obligation aggregate. The packet names no contractors and publishes no outlay total. FEC donations do not fund this USAspending cell. USAspending.gov remains the source for NAICS 325412 in FY2025. The pair is NAICS 325412 plus FY2025.